In the current study, we successfully engineered 231‐exo, an MBA‐DM‐231 breast cancer cell‐derived exosome with a commonly used chemotherapeutic drug, cisplatin and anti‐CD47 antibody. The gene discussed is CD47; the disease is breast carcinoma.